MyoKardia

Bristol Myers

Pharma

BMS says goodbye to its top dealmaker Elizabeth Mily

Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker.

Fraiser Kansteiner Dec 8, 2023 11:25am

Tech platforms replacing late-stage drugs as key M&A targets

Jun 27, 2022 1:35pm

Bristol Myers Squibb new sign outside

Bristol's heart med mavacamten passed muster at the FDA

Apr 29, 2022 3:33am